Basic Information
| LncRNA/CircRNA Name | circSCYL2 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR |
| Sample | breast cancer tissues and cell lines |
| Expression Pattern | down-regulated |
| Function Description | The current study identified that circSCYL2 was downregulated in breast cancer tissues and cell lines, and that circSCYL2 overexpression inhibited cell migration and invasion. This study provides expression profiles of circRNAs in EMT groups of breast cancer cells. |
| Pubmed ID | 32236616 |
| Year | 2020 |
| Title | EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis |
External Links
| Links for circSCYL2 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |